Lakefront Biotherapeutics (LKFT) Prepaid Assets (2013 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Prepaid Assets for 13 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets fell 85.52% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (down 85.52% YoY), while the FY2025 annual figure was $8.2 million, down 75.43% from the prior year.
• Prepaid Assets declined to $4.8 million in Q1 2026 per LKFT's latest filing, from $8.2 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $33.2 million in Q4 2024 and bottomed at $4.8 million in Q1 2026.
• Historically, Prepaid Assets has averaged $20.1 million across 5 years, with a median of $17.1 million in 2023.
• Annual changes were most pronounced in 2023 — Prepaid Assets jumped 156.46% — and 2026, when it tumbled 85.52%.
• Lakefront Biotherapeutics' Prepaid Assets stood at $23.8 million in 2022, then sank by 31.5% to $16.3 million in 2023, then soared by 103.68% to $33.2 million in 2024, then plunged by 75.43% to $8.2 million in 2025, then slumped by 41.47% to $4.8 million in 2026.
• Business Quant data shows LKFT's Prepaid Assets at $4.8 million in Q1 2026, $8.2 million in Q4 2025, and $13.2 million in Q3 2025.